Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 53.47
+2.19 (4.27%)
At close: Mar 10, 2026
SHA:688193 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -7.81 | 8.26 | 23.33 | 64.62 | Upgrade
|
| Depreciation & Amortization | - | 16.9 | 15.57 | 14.45 | 10.02 | Upgrade
|
| Other Amortization | - | 2.65 | 2 | 1.5 | 0.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.14 | 0.05 | -0.14 | -0.76 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.83 | 0.34 | 1.19 | 0.38 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -10.49 | -6.16 | -9.32 | -1.21 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 16.83 | 0.59 | 2.92 | 1.01 | Upgrade
|
| Other Operating Activities | - | 2.82 | 0.43 | 1 | 0.76 | Upgrade
|
| Change in Accounts Receivable | - | 9.45 | 26.66 | -49 | -19.57 | Upgrade
|
| Change in Inventory | - | 2.49 | 0.05 | -10.09 | -2.8 | Upgrade
|
| Change in Accounts Payable | - | -4.13 | -21.42 | 22.32 | -9.63 | Upgrade
|
| Change in Other Net Operating Assets | - | 2.28 | -4.16 | 2.42 | 7.95 | Upgrade
|
| Operating Cash Flow | - | 24.39 | 17.19 | -4.09 | 54.44 | Upgrade
|
| Operating Cash Flow Growth | - | 41.85% | - | - | -41.21% | Upgrade
|
| Capital Expenditures | - | -10.52 | -20.39 | -21.22 | -26.48 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.12 | 0.39 | 0.7 | 1.94 | Upgrade
|
| Investment in Securities | - | -323.75 | 315 | -530 | -0.13 | Upgrade
|
| Other Investing Activities | - | 11.17 | 6.92 | 8.83 | 1.21 | Upgrade
|
| Investing Cash Flow | - | -321.99 | 301.92 | -541.68 | -23.45 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -3.84 | Upgrade
|
| Long-Term Debt Repaid | - | -3.27 | -3.97 | -1.26 | -1.98 | Upgrade
|
| Total Debt Repaid | - | -3.27 | -3.97 | -1.26 | -5.82 | Upgrade
|
| Net Debt Issued (Repaid) | - | -3.27 | -3.97 | -1.26 | -5.82 | Upgrade
|
| Issuance of Common Stock | - | - | - | 675.69 | - | Upgrade
|
| Repurchase of Common Stock | - | -35.66 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -11.71 | -5 | - | -0.05 | Upgrade
|
| Other Financing Activities | - | - | - | -27.14 | 0.91 | Upgrade
|
| Financing Cash Flow | - | -50.64 | -8.97 | 647.29 | -4.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.56 | 0.48 | -0.15 | -0.36 | Upgrade
|
| Net Cash Flow | - | -347.69 | 310.63 | 101.37 | 25.67 | Upgrade
|
| Free Cash Flow | - | 13.86 | -3.2 | -25.31 | 27.97 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -63.71% | Upgrade
|
| Free Cash Flow Margin | - | 7.82% | -1.94% | -8.33% | 9.57% | Upgrade
|
| Free Cash Flow Per Share | - | 0.35 | -0.08 | -0.66 | 0.92 | Upgrade
|
| Cash Income Tax Paid | - | 6.9 | 7.34 | 18.84 | 17.9 | Upgrade
|
| Levered Free Cash Flow | - | 18.4 | -10.09 | -29.74 | -3.93 | Upgrade
|
| Unlevered Free Cash Flow | - | 18.59 | -9.82 | -29.51 | -3.77 | Upgrade
|
| Change in Working Capital | - | 2.8 | -3.91 | -39.03 | -21.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.